Sedana Medical: Initial take on Q1 2023 results - Redeye

Redeye provides an initial take on Sedana Medical’s Q1 results, and we are glad to see our estimates beaten on sales and OPEX. We will return shortly with a more in-depth take on the report following the conference call. We expect the stock to react positively, up some 15% today.

Länk till analysen i sin helhet: https://www.redeye.se/research/898404/sedana-medical-initial-take-on-q1-2023-results?utm_source=finwire&utm_medium=RSS